Research Highlights:
- After a steady decline from 2010-2019, heart disease death rates rose significantly in the U.S with the onset of the COVID-19 pandemic in 2020.
- The increase in the death rate from heart disease represents roughly 5 years of lost progress among all adults and about 10 years of lost progress among Black adults and younger adults.
Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Oct. 31, 2022
(NewMediaWire) - October 31, 2022 - DALLAS — U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022. The meeting, held in person in Chicago and virtually, Nov. 5-7, 2022, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
Death rates from heart disease in the U.S. had been declining among adults since at least the 1990s however, a review of data in 2020 found that heart disease death rates increased across adults in all age groups, sex, race and ethnicity groups, particularly among younger adults and non-Hispanic Black adults, according to the lead study author Rebecca C. Woodruff, Ph.D., M.P.H., an epidemiologist at the Centers for Disease Control and Prevention (CDC).
“Prior to 2020, death rates from heart disease had been declining among adults for decades, which has been recognized by the CDC as one of the ten greatest public health achievements of the last century,” Woodruff said. “The increases in death rates from heart disease in 2020 represented about 5 years of lost progress among adults nationwide and about 10 years of lost progress among younger adults and non-Hispanic Black adults.”
The spread of COVID-19 in the U.S. began prompting school and workplace closings in some states in February 2020. It was declared a global pandemic by the World Health Organization the following month and stay-home orders were widespread. The first COVID-19 vaccinations for adults and some teens were available in December 2020.
“The COVID-19 pandemic disrupted many aspects of daily life, including access to preventive health care, which may have led to delays in detecting and treating heart disease,” Woodruff said. “We expected to see an increase in heart disease death rates among adults, however the magnitude of the increase was striking.”
Researchers analyzed 2010 to 2020 information from the CDC’s Wide-Ranging ONLine Data for Epidemiologic Research (WONDER) database, which aggregates death certificate data across the U.S. from the National Vital Statistics System. Among the findings:
- From 2010 to 2019, the national heart disease death rate dropped by 9.8%; however, in 2020, the rate increased by 4.1%. This setback represented about 5 years of lost progress in reducing heart disease death rates among adults.
- Increases in heart disease death rates were particularly high among younger adults, who experienced approximately 10 years of lost progress. Among 35- to 54-year-old adults, deaths from heart disease fell by 5.5% from 2010 to 2019, yet they jumped by 12% in 2020. Among 55- to 74-year-old adults, heart disease death rates were down by 2.3% between 2010 to 2019, yet they increased by 7.8% in 2020.
- Increases in heart disease death rates were also high among non-Hispanic Black adults, who experienced approximately 10 years of lost progress. Among non-Hispanic Black adults, heart disease death rates declined by 10.4% from 2010 to 2019, then jumped by 11.2% in 2020.
Researchers also noted that while the findings need further investigation, growing evidence suggests people who have had COVID-19 infection may be at an increased risk for new or worsening cardiovascular disease, which may have been a factor in the rising rates from 2019 to 2020.
Other factors associated with the pandemic lockdown, such as lack of physical activity, increased smoking and increased alcohol use, all contributed to the higher cardiovascular death rates, said American Heart Association President Michelle A. Albert, M.D., M.P.H., FAHA, the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco.
“These social determinants of health have a larger effect on people who are economically disadvantaged, Black people, Hispanic people and indigenous and native individuals, so then you have a domino effect resulting in higher death rates and more disease among these populations,” Albert said.
She urged action from both citizens and health care professionals. “If you are a person who has not received medical care for one or more years because of the pandemic, please seek out care from a health care professional. And it’s important for health care professionals to really take a look at their pool of patients to identify those persons who have dropped off their radar and reach out to those people and offer medical assistance, as well as potentially connect them with the social resources that they might need now coming out of the pandemic.”
Woodruff added that the CDC is actively investigating heart disease trends after 2020 to see how the trends have evolved. Meanwhile, there are steps to better manage cardiovascular disease risk going forward.
Everyone can improve their cardiovascular health by following the American Heart Association’s Life’s Essential 8: eating better, being physically active, not smoking, getting enough sleep, maintaining a healthy weight, and controlling cholesterol, blood sugar and blood pressure levels. Cardiovascular disease claims more lives each year in the United States than all forms of cancer and chronic lower respiratory disease combined, according to the American Heart Association.
Co-authors are Xin Tong, M.P.H.; Sandra L. Jackson, Ph.D.; Fleetwood V. Loustalot, Ph.D.; and Adam S. Vaughan, Ph.D. Authors’ disclosures are listed in the abstract.
The study was funded by the Centers for Disease Control and Prevention.
Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
Additional Resources:
- Multimedia is available on the right column of the release link https://newsroom.heart.org/news/heart-disease-death-rates-spiked-during-the-covid-19-pandemic-erasing-years-of-progress?preview=e5fa565eedc6b411cf332ad474037273
- Spanish news release
- Link to abstract and AHA Scientific Session 2022 Online Program Planner
- AHA news release: Social isolation and loneliness increase the risk of death from heart attack, stroke (Aug. 2022)
- AHA news release: U.S. adults’ blood pressure levels increased during the COVID-19 pandemic (Dec. 2022)
- AHA news release: Reduced air pollution in U.S. during pandemic shutdown linked to fewer heart attacks (Nov. 2021)
- AHA newsroom: COVID-19 Newsroom
- For more news at AHA Scientific Sessions 2022, follow us on Twitter @HeartNews #AHA22
The American Heart Association’s Scientific Sessions 2022 is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The 3-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates occurring Saturday through Monday, November 5-7, 2022. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2022 on social media via #AHA22.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
###
For Media Inquiries and AHA Expert Perspective:
AHA Communications & Media Relations in Dallas: 214-706-1173; ahacommunications@heart.org
Bridgette McNeill: 214-706-1135; bridgette.mcneill@heart.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
